No worries, @Owl vs Fox.
I prefer to read the research firstly to see the basis of which Imugene have created their developmental drugs on. I may not understand it entirely but it gives some further insights about how at least it works pre-clinically.
I'm in the webinar at the moment and I believe one of the researchers has mentioned that, as far as their knowledge goes, no one else is working in this space. I recall he was responding to a question about whether other companies are doing something similar as the OnCARlytics combination. They truly have a solid scientific team.
If anyone wants the full research article by Park et al. (2020), please let me know.
No worries, @Owl vs Fox.I prefer to read the research firstly to...
-
- There are more pages in this discussion • 72 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.3¢ |
Change
-0.001(1.85%) |
Mkt cap ! $389.5M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.6¢ | 5.3¢ | $615.0K | 11.39M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 2977440 | 5.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.4¢ | 283236 | 4 |
View Market Depth
| Last trade - 16.10pm 30/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |